Discover Great Companies Discover Great Clients
Popularity  16万   |   Followers  67   |   Likes  35   |   Feedback  44 Claim this company

Research and development and industrialization of monoclonal antibody

No.240 Shanghai Popularity Ranking No.27 Xuhui District No.1 抗体药 No.2 医药创新 No.3 单克隆抗体药物 No.3 抑制剂 No.3 注射液 No.3 单克隆抗体 No.3 单克隆抗体研究 No.4 医药集团 No.5 抗体 No.8 原研药 No.8 创新药物 No.10 生物科技/生物工程 独角兽企业 高新技术企业 瞪羚企业 省级创新型中小企业 省级专精特新中小企业 市级创新型中小企业 GMP认证

Henlius funding history / development milestones

IPO,

2019.09.25,

B轮,1.9亿美元

2018.01.12, 高特佳投资

战略投资,1.9亿美元

A轮,1900万美元

2016.07.29, 华盖资本

天使轮,400万人民币

2016.03.01, 方正和生投资

Note: collected from public online reports, for reference only.

People who follow Henlius also follow

Henlius Competitors (Similar Companies)

制药/药业 诊断试剂 生物制药 干细胞
“Promoting human health”
“Research, development, and production of anti-tumor and surgical medic”
“To develop high-quality biologics that are accessible and affordable f”
“Continuously innovating to bring patients medicines that significantly”
“In the rapidly growing biopharmaceutical field, accelerate and transfo”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Helping partners successfully develop new drugs, reducing R&D costs an”
人用疫苗 动物保健品 动物保健 罕见病
“Technological innovation and commercial application of pharmaceutical ”
“Helping patients access more effective medicines sooner”
“Professional services for the entire clinical trial process of drug pr”
“Enable people to access information and find what they need in an equa”
“Global integrated biopharmaceutical enterprise”

Discover Great Companies, Discover Great Clients

Shanghai最新融资 全国“医药”最新融资 全国“制药/药业”最新融资 全国“生物医药”最新融资 全国“抗体药”最新融资 全国“药物研发”最新融资 附近的公司